Willow active extract of the bark, called salicin, was isolated to its crystalline form in 1828 by Henri Leroux, a French pharmacist, and Raffaele Piria, an Italian chemist, who then succeeded in separating out the compound in its pure state. In 1897, Felix Hoffmann created a synthetically altered version of salicin (in his case derived from the "Spiraea" plant), which caused less digestive upset than pure salicylic acid. The new drug, formally acetylsalicylic acid, was named Aspirin by Hoffmann's employer Bayer AG. This gave rise to the hugely important class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). Some of humans'
Phenylarsonic acid was first prepared by Michaelis and Loenser. X-ray crystallography indicates that the molecules are connected by hydrogen-bonds consistent with short distance of 2.5 Å separating the oxygen atoms. The arsenic center is tetrahedral. Several derivatives of phenylarsonic acid have been used as additives for animal feeds. These include 4-hydroxy-3-nitrobenzenearsonic acid (3-NHPAA, or Roxarsone), "p"-arsanilic acid ("p"-ASA), 4-nitrophenylarsonic acid (4-NPAA), and "p"-ureidophenylarsonic acid ("p"-UPAA). Phenylarsonic acid Phenylarsonic acid is the chemical compound with the formula CHAsO(OH), commonly abbreviated PhAsOH. This colourless solid is an organic derivative of arsenic acid, AsO(OH), where one OH group has been replaced by a phenyl group.